Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-24-000026
Filing Date
2024-01-08
Accepted
2024-01-08 09:09:25
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING AMICUS THERAPEUTICS, INC. Amicus_Therapeutics_Inc.ht.htm SC 13G 88128
  Complete submission text file 0000019617-24-000026.txt   90104
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Subject) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)